INDIANAPOLIS (AP) — Eli Lilly Chairman and CEO John Lechleiter is back to full-time work after taking a leave in May to have surgery for a dilated aorta.
The Indianapolis drugmaker says both a company doctor and Lechleiter's personal physician have cleared the 59-year-old to return.
Lechleiter had the surgery May 13. Chief Financial Officer Derica Rice served as acting CEO, and independent director Ellen Marram served as acting chairwoman.
Lechleiter was expected to make a full recovery from the surgery. The aorta is the largest blood vessel in the body, and Lechleiter's condition was discovered during unrelated testing. The executive had not experienced any symptoms.
Eli Lilly and Co. makes the antidepressant Cymbalta as well as several treatments for diabetes and forms of cancer.
Shares of Eli Lilly rose 29 cents to $50.87 in premarket trading Monday.
An Unserious Candidate for an Unserious Country | RedState
Obama's Special Assistant Resigns After Being Charged For Shooting At Police Officer - Bearing Arms - Barack Obama, Barvetta Singletary, Crime, Maryland
WaPo: Clinton personally paid State Dept employee to maintain private server
Todd Starnes - Judicial Tyranny: Why Kim Davis May Not be the Last
Peter Schiff - Meet QT; QE's Evil Twin
The Koran’s Contents—Not Carbon Dating—Cast More Doubt on Islam’s Origins | Human Events
'Becoming clearer why Pagliano took the Fifth': Tale of Hillary's server takes another twist